论文部分内容阅读
目的了解基本药物制度背景下慢性病患者用药依从性的影响因素。方法利用Morisky患者用药依从性问卷测量1 200名慢性病患者用药依从性,并对数据进行单因素与多因素分析。结果慢性病患者对基本药物制度知晓率为50.7%(608/1 200);63.8%(765/1 200)的慢性病患者用药依从性表现较好,城市患者用药依从性为64.3%(222/345),好于农村的63.5%(543/855),不发达地区患者用药依从性为66.1%(517/782),好于经济发达地区的59.3%(248/418),<40岁人群患者用药依从性为71.6%(96/134),好于其他年龄组的62.8%(669/1 066);慢性病患者用药依从性的影响因素主要包括患者用药偏好、基层医疗机构的药物供应与用药指导等。结论当前应在基本药物制度顶层设计优化、慢性病患者用药偏好矫正与基层医疗机构用药指导方面加大建设力度。
Objective To understand the influencing factors of drug compliance in patients with chronic diseases under the background of essential drugs. Methods The medication adherence of 1 200 patients with chronic diseases was measured by Morisky medication compliance questionnaire, and the data were analyzed by single factor and multivariate analysis. Results The rate of awareness of the basic drug system was 50.7% (608/1 200) in patients with chronic diseases, and 63.8% (765/1 200) in patients with chronic diseases showed good drug compliance. The medication compliance in urban patients was 64.3% (222/345) , Which was better than 63.5% (543/855) in rural areas and 66.1% (517/782) in under-developed areas, which was better than 59.3% (248/418) in economically developed areas. Patients in <40 years of age had medication compliance The positive rate was 71.6% (96/134), which was 62.8% (669/1 066) higher than the other age groups. The influencing factors of drug compliance in patients with chronic diseases mainly included the preference of patients, the drug supply and medication guidance of primary medical institutions. Conclusion At present, it is necessary to intensify the construction of top-level drug design and optimization, medication preference correction for chronic patients and guidance on medication administration in primary medical institutions.